what is the new glp 1 drug Retatrutide for weight loss: Study shows 30% body weight loss New oral GLP-1 drug delivers

Insulin-like growth factor 1 inhibits hair cell apoptosis and promotes the cell cycle of supporting cells by activating different downstream cascades after pharmacological hair cell injury in neonatal mice

doi: 10.1378/chest.12-3073 65 TrompetteAGollwitzerESYadavaKSichelstielAKSprengerNNgom-BruCet al

Therefore, this review hypothesizes that mitochondria serve as central hubs regulating oxidative stress, inflammation, and aging, and their dysfunction contributes to various diseases, including cancers, cardiovascular diseases, neurodegenerative disorders, metabolic diseases, sepsis, ocular pathologies, liver diseases, and autoimmune conditions

#Relumins #WatsonsPH | Watsons